NeuroTherapeutics Pharma Obtains $43,000,000 Series B Financing

  • Feed Type
  • Date
    5/20/2010
  • Company Name
    NeuroTherapeutics Pharma
  • Mailing Address
    8420 West Bryn Mawr Avenue Chicago, IL 60631
  • Company Description
    NeuroTherapeutics Pharma (NTP) is an early stage company focused on the development of therapies for CNS disorders with an initial focus on epilepsy.
  • Website
    http://www.ntprx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $43,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company’s Series B financing will advance NTP-2014 up to and through multiple proof-of-concept Phase II trials and further develop a pipeline to expand this new class of therapy.
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    MPM Capital
  • Venture Investor
    Fidelity BioSciences
  • Venture Investor
    Novo A/S
  • Venture Investor
    Pfizer Strategic Investments Group
  • Venture Investor
    Thomas, McNerny & Partners

By posting a comment, you agree to our terms and conditions.